AC FORUM 2019
Search

 Thursday Apr 11

Session 1 Rapid Fire - What's New Since the Last ACF Conference?
Top Papers from the Last Year You Need to Know About
Apr 11 - 10:45 AM
Tracy Minichiello
University of California, San Francisco
New Antithrombotic Agents
Apr 11 - 10:45 AM
Deborah Siegal
McMaster University
Guidance Updates from ASH and ACC
Apr 11 - 10:45 AM
Daniel Witt
University of Utah College of Pharmacy
Session 2 Combined Therapy - AFib, Coronary and Peripheral Disease
Anticoagulants for Secondary Prevention of CAD/PAD
Apr 11 - 2:15 PM
John Eikelboom
McMaster University
What is PAD and How Should I Treat It?
Apr 11 - 2:15 PM
Heather Gornik
Cleveland Clinic
Combined Antithrombotic Therapy: Is There a Role for it in 2019?
Apr 11 - 2:15 PM
Renato Lopes
Duke University

 Friday Apr 12

Session 3 Optimizing Anticoagulation Clinics
State of Anticoagulation Management Services
Apr 12 - 8:30 AM
Geoff Barnes
University of Michigan
Optimizing Warfarin
Apr 12 - 8:30 AM
Nathan Clark
Kaiser Permanente Colorado
Practical Issues with Transitioning to DOAC Clinic
Apr 12 - 8:30 AM
Lynn Oertel
Massachusetts General Hospital
Session 4 Controversies and Challenges in VTE
Debate: VTE Treatment - Drug, Duration Dose
Apr 12 - 10:45 AM
Michael Streiff
Johns Hopkins
Debate: VTE Treatment - Drug, Duration Dose
Apr 12 - 10:45 AM
Arthur Allen
VA Salt Lake City Health Care System
Diagnostic Imaging Dilemmas in VTE
Apr 12 - 10:45 AM
Marc Carrier
Ottawa Hospital Research Institute
Managing VTE in Cancer Patients
Apr 12 - 10:45 AM
David Garcia
University of Washington
Session 5 Moving the Needle - Creating Change at the National Level
Update from CMS
Apr 12 - 2:00 PM
Michelle Schreiber
Centers for Medicare and Medicaid Services
The Joint Commission New Patient Safety Goals
Apr 12 - 2:00 PM
Andrew Bland
The Joint Commission
Session 6 Improving Safety and Quality in Anticoagulation Care
Transitions of Care
Apr 12 - 4:15 PM
Allison Burnett
University of New Mexico Health Sciences Center
Bridging Difficult Cases
Apr 12 - 4:15 PM
Elaine Hylek
Boston University School of Medicine
Shared Decision Making
Apr 12 - 4:15 PM
Eva Kline-Rogers
University of Michigan
Clinically Important Drug-Drug Interactions
Apr 12 - 4:15 PM
Sara Vazquez
University of Utah Health

 Saturday Apr 13

Session 7 Cornucopia of Issues in Anticoagulation
DOAC Reversal: Is it Necessary?
Apr 13 - 9:30 AM
Mark Crowther
McMaster University
Focused Updates on Antithrombotics in AFib
Apr 13 - 9:30 AM
Alan Jacobson
Loma Linda University Medical Center
Women's Health and Anticoagulation
Apr 13 - 9:30 AM
Bethany Samuelson Bannow
Oregon Health and Science University